Skip to content

13F-HR filed by Nextech Invest Ltd.

Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 13 holding rows worth $294,203,998.

Accession
0001104659-23-091377
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 13 entries on the cover page, a total value of $294,203,998 stated on the cover page (in dollars after the unit check, H1), rows summing to $294,203,998 with VALUE read as dollars as filed, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock4,839,529$129,457,401dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK2,518,582$42,891,451dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,285,714$33,257,141dollars as filed
EQRX INC26886C107COM13,104,424$24,374,229dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,221,145$13,139,520dollars as filed
ARS PHARMACEUTICALS INC82835W108COM1,910,029$12,797,194dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock948,659$11,915,157dollars as filed
ARVINAS INC04335A105COM287,251$7,129,570dollars as filed
KINNATE BIOPHARMA INC49705R105COM2,329,480$7,058,324dollars as filed
THESEUS PHARMACEUTICALS INC88369M101COM611,310$5,703,522dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM471,284$2,950,238dollars as filed
KRONOS BIO INC50107A104COM1,451,537$2,496,644dollars as filed
C4 THERAPEUTICS INC12529R107COM STK375,857$1,033,607dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-091377this filing2023-08-14acceptance time not in the bulk data set